Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Meghen B. Browning MD

Meghen B. Browning MD

Assistant Professor

Institution: Medical College of Wisconsin
Department: Pediatrics
Division: Hematology/Oncology
Program: Oncology

Member of the Cancer Center


Research Experience

  • Immunotherapy
  • Neuroblastoma
  • Clinical Expertise

  • Neoplasms, Bone Tissue
  • Neoplasms, Germ Cell and Embryonal
  • Neuroblastoma
  • Osteosarcoma
  • Rhabdomyosarcoma
  • Sarcoma, Ewing's
  • Soft Tissue Neoplasms
  • Publications

  • Expanding the phenotype of multifocal lymphangioendotheliomatosis with thrombocytopenia. (Maronn M, Catrine K, North P, Browning MB, Kerschner JE, Noel R, Drolet BA, Kelly M) Pediatr Blood Cancer 2009 Apr;52(4):531-4 PMID 19058203
  • Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis. (Keever-Taylor CA, Browning MB, Johnson BD, Truitt RL, Bredeson CN, Behn B, Tsao A) Cytotherapy 2007;9(2):144-57 PMID 17453966
  • The T cell activation marker CD150 can be used to identify alloantigen-activated CD4(+)25+ regulatory T cells. (Browning MB, Woodliff JE, Konkol MC, Pati NT, Ghosh S, Truitt RL, Johnson BD) Cell Immunol 2004 Feb;227(2):129-39 PMID 15135295
  • The surgeon's role in pediatric orbital malignancies: an oncologist's perspective. (Browning MB, Camitta BM) Ophthal Plast Reconstr Surg 2003 Sep;19(5):340-4 PMID 14506417